January 30, 2018 /

Italfarmaco Provides Givinostat Update (January 2018)

Parent Project Muscular Dystrophy by: Parent Project Muscular Dystrophy

Italfarmaco Provides Givinostat Update (January 2018)

Italfarmaco joined PPMD for a webinar on January 24, 2018 to update the Duchenne community about Italfarmaco’s development of Givinostat and currently enrolling Phase 3 confirmatory study in Duchenne muscular dystrophy.

Research & Clinical Trial Webinars,
Webinars

Join Our Mailing List

BBB Accredited Charity logoCharity Navigator Four Star Charity logoNational Health Council Standards of Excellence Certification Program logo